Close Menu

SAN FRANCISCO (GenomeWeb) – Researchers are turning to next-generation sequencing to develop better methods for cataloguing mutations that confer tuberculosis drug resistance and, ultimately, to design better diagnostics.

According to the World Health Organization, 80 percent of people infected with multi-drug resistant tuberculosis in 2015 did not receive the appropriate treatment, and only half of those who started treatment were cured. This is compared to a more than 90 percent cure rate for tuberculosis that is not resistant.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.